Home > News > Molecular Imprints, Inc. Secures Carl Zeiss as Investor
December 2nd, 2003
Molecular Imprints, Inc. Secures Carl Zeiss as Investor
Abstract:
Molecular Imprints, Inc. (MII) has reached an investment and collaboration agreement with Carl Zeiss SMT AG, a global supplier to the semiconductor industry and a wholly owned corporation of the German-based Carl Zeiss Group. Carl Zeiss SMT has agreed to make an equity investment in MII and has also obtained the exclusive
rights to distribute MII's imprint lithography equipment in Europe for its LEO Division. The Carl Zeiss SMT investment is part of MII's Series B $30 million funding round.
Source:
PRNewswire
Bookmark:
Investments/IPO's/Splits
Elsevier Business Intelligence (EBI) to Host 'IN3 Medical Device 360 Boston,' June 24-26, 2013 May 20th, 2013
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013
Nanometrics Announces Upcoming Investor Events May 14th, 2013